炎琥宁与更昔洛韦治疗病毒性肺炎的成本-效果分析
cost-effectiveness of two different treatments for the viral pneumonia with ganciclovir or potassium sodium dehydroandrograpolide succinate for injection
赵足华 1毛永莲1
作者信息
- 1. 湖南省娄底市第一人民医院药剂科 湖南娄底 417000
- 折叠
摘要
目的：探讨应用炎琥宁和更昔洛韦治疗病毒性肺炎的疗效、不良反应及成本-效果比差异。方法采用回顾性分析，选择2012年1月～2014年1月病毒性肺炎患者112例，将以上患者随机分为两组，炎琥宁组和更昔洛韦组。确定两组患者成本，分析两组患者成本效果。结果两组患者总有效率比较，差异无统计学意义（P>0.05）；获得1个单位效果情况下，更昔洛韦组所用成本小于炎琥宁组，差异有统计学意义（P＜0.05）。结论更昔洛韦组静滴方案临床效果显著且成本较小。
Abstract
Objective To investigate the cost-effectiveness of two different treatments for the viral pneumonia with ganciclovir or potassium sodium dehydroandrograpolide succinate for injection. Methods Chose 112 patients with viral pneumonia from January 2012 to January 2014,and divided them into two groups,potassium sodium dehydroandrograpolide succinate group and ganciclovir group. Results The total effective rates in two groups were not different(P>0.05);after 1 unit of effect,the cost in the ganciclovir group was smal er than that in the potassium sodium dehydroandrograpolide succinate group. Conclusion The clinical effect of ganciclovir is remarkable,and the cost is smal .
关键词
病毒性肺炎/成本效果/更昔洛韦/炎琥宁Key words
viral pneumonia/Cost effectiveness/ganciclovir/potassium sodium dehydroandrograpolide succinate引用本文复制引用
出版年
2014
NETL
NSTL
万方数据